Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (6): 924-930    DOI: 10.31083/j.ejgo.2020.06.2118
Original Research Previous articles | Next articles
Clinical and prognostic value of pre-operative systemic inflammatory markers in clinical course and prognosis of ovarian cancer
Haci Ozturk Sahin1, *(), Zelal Aydin2, Ibrahim Ugras Toktas3, Cetin Toraman4, Ilkbal Temel Yuksel5, Alper Seyhan5, Ozgur Akbayir5
1Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Canakkale Onsekiz Mart University, 17110, Canakkale, Turkey
2Department of Obstetrics and Gynecology, Kanuni Sultan Suleyman Training and Research Hospital, 34303, Istanbul, Turkey
3Department of Obstetrics and Gynecology, Canakkale Onsekiz Mart University, 17110, Canakkale, Turkey
4Department of Basic Medical Sciences, Canakkale Onsekiz Mart University, 17020, Canakkale, Turkey
5Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Kanuni Sultan Suleyman Training and Research Hospital, 34303, Istanbul, Turkey
Download:  PDF(410KB)  ( 92 ) Full text   ( 11 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objectives: Inflammation plays an important role in the pathogenesis of ovarian cancer. The prognostic value of systemic inflammatory markers is gaining importance in cancer patients. The aim of the present study is to evaluate the clinical and prognostic value of several inflammation markers to include neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) and C-reactive protein (CRP), examined pre-operatively in epithelial ovarian cancer patients. Design: Retrospective clinical study. Subjects: A total of 97 patients with epithelial ovarian cancer who underwent primary staging surgery or debulking surgery were analyzed retrospectively. The influence of NLR, PLR values on overall survey (OS) was tested with Kaplan-Meier method and clinical-pathological parameters were tested with chi-square test. Proportional influence of clinical-pathological data on overall survival was tested with hazard ratio uni-variate and multi-variate analyses. Results: Median values of NLR, PLR and CRP were accepted as cut-off value. While elevated NLR (> 2.94) was associated with elevated CA-125 values (p = 0.002), excess amount of ascites (p = 0.023) and presence of residual tumor (p = 0.036); elevated PLR was associated with elevated CA-125 values (p < 0.001), excess amount of ascites (p = 0.001), presence of residual tumor (p = 0.003) and advanced stage (p = 0.013). Elevated CRP values were associated with only elevated CA-125 values (p = 0.013) and excess amount of ascites (p = 0.046). In uni-variate analysis, presence of post-operative residual tumor, > 500 cc ascites, NLR and PLR values were associated with OS; in multi-variate analysis, only stage (p = 0.019) and presence of post-operative residual tumor (p = 0.016) were found to be independent risk factors for OS. Conclusion: Novel prognostic biomarkers are urgently needed for better prediction of survival and definition of novel therapeutic targets.
Key words:  Systemic inflammatory markers      Prognosis      Ovarian cancer     
Submitted:  27 April 2020      Accepted:  06 July 2020      Published:  15 December 2020     
*Corresponding Author(s):  HACI OZTURK SAHIN     E-mail:  ozturksahin@comu.edu.tr

Cite this article: 

Haci Ozturk Sahin, Zelal Aydin, Ibrahim Ugras Toktas, Cetin Toraman, Ilkbal Temel Yuksel, Alper Seyhan, Ozgur Akbayir. Clinical and prognostic value of pre-operative systemic inflammatory markers in clinical course and prognosis of ovarian cancer. European Journal of Gynaecological Oncology, 2020, 41(6): 924-930.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.06.2118     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I6/924

[1] Francesco Plotti, Bartolone Martina, Terranova Corrado, Luvero Daniela, Scaletta Giuseppe, Gatti Alessandra, Benedetti Panici Pierluigi, Angioli Roberto. Role of human epididymis protein 4 (HE4) as predictor of response to platinum based chemotherapy: a systematic review of literature[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 889-896.
[2] Irina Esteves-Krasteva, José Ángel Minguez, José María Aramendía, Marta Santisteban, Fernando Martinez-Regueira, Gabriel Zozaya-Larequi, Juan Luis Alcázar, Matías Jurado. Complete cytoreductive surgery, the key factor for survival in advanced ovarian cancer. Experience of an intermediate volume hospital[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 906-912.
[3] Sefa Kurt, Selim Kandemir, Onur Yavuz, Meral Koyuncuoglu, Emine Cagnur Ulukus, Murat Celiloglu. Persistent tubal epithelium in ovaries after salpingectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 919-923.
[4] Hiroshi Yoshida, Megumi Yamamoto, Hiroyuki Shigeta, Miwa Yasaka, Hiroko Machida, Masae Ikeda, Masako Shida, Takeshi Hirasawa, Mikio Mikami. Usefulness of laparoscopic restaging surgery for patients diagnosed with apparent early ovarian/fallopian tubal cancer by a prior surgery, a case control observational study in a single institute in Japan[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 960-968.
[5] Fatih Kose, Songül Alemdaroğlu, Hüseyin Mertsoylu, Ali Ayberk Beşen, Ozan Cem Güler, Seda Yüksel Şimşek, Gürcan Erbay, Cem Önal, Hüsnü Çelik. Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 989-995.
[6] Hideki Iwahashi, Morikazu Miyamoto, Takahiro Sakamoto, Hiroki Ishibashi, Soichiro Kakimoto, Hiroko Matsuura, Hitoshi Tsuda, Masashi Takano. Low-grade serous ovarian carcinoma is a rare histological subtype in Japan[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 1004-1009.
[7] R van de Vrie, E van Werkhoven, M J Rutten, J D Asseler, H S van Meurs, D E Werter, M R Buist, A.H. Zwinderman, C A R Lok, P.M.M. Bossuyt, G G Kenter, P Tajik. Validation of a treatment-selection rule for patients with advanced stage ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 1023-1030.
[8] Buse Güler, Merve Çamlıbel, Samiye Mete. What Do Relatives of Turkish Women with Ovarian Cancer Share on Websites? : A Qualitative Research[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 732-738.
[9] Wook Youn Kim, Shin Hee Seo, Seung-Hyuk Shim, Jin Hee Park, Hyung Kyu Park, Kyeong A So, Tae Jin Kim, Sun Joo Lee. Correlation of immunohistochemistry and silver in situ hybridization for the assessment of c-MET in uterine cervical cancer patients treated with radical hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 745-752.
[10] Yudi Mulyana Hidayat, Gatot Nyarumenteng Adhipurnawan Winarno, Maringan Diapari Lumban Tobing, Arieff Kustiandi, Kemala Isnainiasih Mantilidewi, Sofie Rifayani Krisnadi. The Role of Akt2 and CA-125 Serum Levels as Predictors for Successful Cytoreduction in Epithelial Ovarian Cancer Surgery[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 739-744.
[11] Lingyun Zhai, Lixin Zeng, Hongru Jiang, Wei Li. Effects of a cyclooxygenase-1-selective inhibitor in combination with taxol or cisplatin on cyclin D1, apoptosis, and vascular endothelial growth factor in a xenograft model of ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 779-784.
[12] Qinglian Ma, Wenjie Yan, Jing Yang, Haiyan Wang, Weixiang Wang, Minghui Dong. Functional interpretation of ovarian cancer in correlation with ISGF3 expression pattern[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 769-773.
[13] Chados Nikolaos, Gregoriou Odysseas, Salakos Nicolaos, Kondis Agatha, Deligeoroglou Efthymios. The prognostic significance and immuno-expression of survivin, mutant p53 and bcl-2 in 92 cases of epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 517-522.
[14] Silvia Ortega, José Angel Mínguez, José Manuel Aramendía, Marta Santisteban, Fernando Martinez-Regueira, Pablo Martí-Cruchaga, Juan Luis Alcázar, Matías Jurado. The impact of secondary cytoreductive surgery on survival in first recurrence of platinum sensitive epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 523-530.
[15] Sun Yi Choe, Jung-Woo Park. Prognostic significance of the number of metastatic lymph nodes in early cervical cancer: a retrospective study[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 536-540.
No Suggested Reading articles found!